Clover Health Investments Profit Margin 2020-2025 | CLOV
Current and historical gross margin, operating margin and net profit margin for Clover Health Investments (CLOV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Clover Health Investments net profit margin as of September 30, 2025 is -3.29%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.044B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |